Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-16 Sale |
2020-11-18 4:19 pm |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer |
25,000 | $169.57 | $4,239,148 | 519,783 (Direct) |
View |
| 2020-11-12 Sale |
2020-11-13 3:53 pm |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
4,000 | $172.92 | $691,669 | 6,000 (Direct) |
View |
| 2020-11-12 Sale |
2020-11-13 3:44 pm |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
3,500 | $176.02 | $616,070 | 21,580 (Direct) |
View |
| 2020-11-11 Sale |
2020-11-12 5:03 pm |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
51,429 | $179.37 | $9,224,669 | 63,674 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-10 5:59 pm |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer |
25,000 | $175 | $4,375,000 | 72,000 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-10 5:54 pm |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
4,000 | $150.01 | $600,040 | 15,000 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-10 5:43 pm |
REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer |
81,657 | $175.01 | $14,291,048 | 28,166 (Indirect Direct) |
View |
| 2020-11-09 Sale |
2020-11-10 5:30 pm |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
60,000 | $162.5 | $9,750,300 | 150,000 (Direct) |
View |
| 2020-08-14 Purchase |
2020-08-14 3:45 pm |
REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO and CFO |
3,000 | $100.21 | $300,630 | 3,000 (Direct) |
View |
| 2020-06-01 Sale |
2020-06-01 5:27 pm |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
2,000 | $143.97 | $287,940 | 23,580 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-04 Option Award |
2021-01-06 4:43 pm |
N/A 2031-01-04 |
REATA PHARMACEUTICALS INC | RETA | Soni Manmeet Singh COO and CFO |
24,000 | $0 | 24,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:40 pm |
N/A 2031-01-04 |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer |
24,000 | $0 | 24,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:38 pm |
N/A 2031-01-04 |
REATA PHARMACEUTICALS INC | RETA | Huff James Warren Chief Executive Officer |
44,600 | $0 | 1,505,542 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:13 pm |
N/A 2031-01-04 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
8,000 | $0 | 8,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:10 pm |
N/A 2031-01-04 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
16,500 | $0 | 16,500 (Direct) |
View |
| 2020-12-23 Other |
2020-12-29 5:42 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner |
166,666 | $0 | 3,126,659 (Indirect) |
View |
| 2020-12-23 Other |
2020-12-29 5:35 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | CPMG Inc Director 10% Owner |
166,666 | $0 | 3,063,567 (Indirect) |
View |
| 2020-11-18 Gift |
2020-11-19 4:08 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
600 | $0 | 14,546 (Direct) |
View |
| 2020-11-16 Conversion |
2020-11-18 4:19 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer |
25,000 | $0 | 519,783 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 4:19 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer |
25,000 | $0 | 519,783 (Direct) |
View |
| 2020-11-16 Exercise |
2020-11-18 4:19 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer |
25,000 | $11 | 519,783 (Direct) |
View |
| 2020-11-12 Conversion |
2020-11-13 3:53 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
4,000 | $0 | 6,000 (Direct) |
View |
| 2020-11-12 Exercise |
2020-11-13 3:53 pm |
N/A 2027-06-14 |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
4,000 | $0 | 6,000 (Direct) |
View |
| 2020-11-12 Exercise |
2020-11-13 3:53 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
4,000 | $25.52 | 6,000 (Direct) |
View |
| 2020-11-12 Conversion |
2020-11-13 3:44 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
3,500 | $0 | 21,580 (Direct) |
View |
| 2020-11-12 Exercise |
2020-11-13 3:44 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
3,500 | $0 | 21,580 (Direct) |
View |
| 2020-11-12 Exercise |
2020-11-13 3:44 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
3,500 | $11 | 21,580 (Direct) |
View |
| 2020-11-11 Conversion |
2020-11-12 5:03 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
51,429 | $0 | 63,674 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-12 5:03 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
51,429 | $0 | 63,674 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-12 5:03 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
12,245 | $11 | 63,674 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-12 5:03 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | WORTLEY MICHAEL D Chief Legal Officer |
39,184 | $17.43 | 63,674 (Direct) |
View |
| 2020-11-09 Conversion |
2020-11-10 5:54 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
4,000 | $0 | 15,000 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 5:54 pm |
N/A 2027-03-01 |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
4,000 | $0 | 15,000 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 5:54 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
4,000 | $26.46 | 15,000 (Direct) |
View |
| 2020-11-09 Conversion |
2020-11-10 5:30 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
60,000 | $0 | 150,000 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 5:30 pm |
N/A 2026-09-06 |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
60,000 | $0 | 150,000 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 5:30 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Bir Dawn Carter Chief Commercial Officer |
60,000 | $21.05 | 150,000 (Direct) |
View |
| 2020-08-03 Option Award |
2020-08-04 4:41 pm |
N/A 2030-08-03 |
REATA PHARMACEUTICALS INC | RETA | Edwards Martin Director |
16,300 | $0 | 16,300 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-22 8:25 pm |
N/A 2030-06-10 |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner |
6,300 | $0 | 6,999 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-22 8:25 pm |
N/A 2030-06-10 |
REATA PHARMACEUTICALS INC | RETA | McGaughy R Kent Jr Director 10% Owner |
699 | $82.15 | 6,999 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-22 6:28 pm |
N/A 2030-06-10 |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Member of 10% owner group Director 10% Owner |
6,300 | $0 | 7,060 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-22 6:28 pm |
N/A 2030-06-10 |
REATA PHARMACEUTICALS INC | RETA | ROSE WILLIAM Member of 10% owner group Director 10% Owner |
760 | $82.15 | 7,060 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-22 4:39 pm |
N/A 2030-06-10 |
REATA PHARMACEUTICALS INC | RETA | Nielsen Jack Director |
6,300 | $0 | 7,578 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-22 4:39 pm |
N/A 2030-06-10 |
REATA PHARMACEUTICALS INC | RETA | Nielsen Jack Director |
1,278 | $82.15 | 7,578 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-22 4:34 pm |
N/A 2030-06-10 |
REATA PHARMACEUTICALS INC | RETA | McClellan William D. Jr. Director |
6,300 | $0 | 6,300 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-22 4:22 pm |
N/A 2030-06-10 |
REATA PHARMACEUTICALS INC | RETA | Bass James Edward Director |
6,300 | $0 | 7,121 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-22 4:22 pm |
N/A 2030-06-10 |
REATA PHARMACEUTICALS INC | RETA | Bass James Edward Director |
821 | $82.15 | 7,121 (Direct) |
View |
| 2020-06-01 Conversion |
2020-06-01 5:27 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
2,000 | $0 | 23,580 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-01 5:27 pm |
N/A 2026-05-25 |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
2,000 | $0 | 23,580 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-01 5:27 pm |
N/A N/A |
REATA PHARMACEUTICALS INC | RETA | Castellanos Elaine VP, Chief Accounting Officer |
2,000 | $11 | 23,580 (Direct) |
View |